Imugene Limited (AU:IMU) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Imugene Limited has announced the application for quotation of new securities on the Australian Securities Exchange (ASX), with a total of 1,060,421 ordinary fully paid shares to be quoted. The issue date for these shares was September 3, 2024, as the company expands its financial footprint. This move could indicate a strategic growth phase for the biotech entity, capturing the interest of investors in the stock market.
For further insights into AU:IMU stock, check out TipRanks’ Stock Analysis page.